Skip to content
HomeLatest newsJohnson & Johnson COVID-19 vaccine named one of Time‘s Best Inventions of 2021.
A brick wall at Johnson & Johnson's headquarters

Johnson & Johnson COVID-19 vaccine named one of Time‘s Best Inventions of 2021.

The vaccine is one of three COVID-19 vaccines sharing joint recognition on the list of groundbreaking innovations this year.

Share Article
share to

Yesterday, the editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time‘s Best Inventions of 2021.

The vaccine, for which Johnson & Johnson received Emergency Use Authorization from the U.S. Food and Drug Administration in February, is being recognized in the Medical Care category alongside two other COVID-19 vaccines.

Since Johnson & Johnson’s founding 135 years ago, it has been committed to using its reach and size for good. In fact, earlier this year, Johnson & Johnson was chosen for inclusion on the first-ever list of TIME100 Most Influential Companies.

Each year, Time highlights groundbreaking inventions across a range of categories—including technology, beauty, healthcare, food, home and entertainment—that are making the world better and smarter and changing the way we live, work, play and think about what’s possible.

Nominations are solicited from editors and correspondents around the world and through an online application process, then evaluated on criteria including originality, creativity, effectiveness, ambition and impact. This year’s list features 100 innovations from around the globe. (You can check out the 2020 winners here.)

Since Johnson & Johnson’s founding 135 years ago, the company has been committed to using its reach and size for good, creating healthier communities and putting a healthy mind, body and environment within reach of everyone, everywhere.

In fact, earlier this year, Johnson & Johnson was chosen for inclusion on the first-ever list of TIME100 Most Influential Companies.

Johnson & Johnson is proud to be named to Time‘s Best Inventions list once again.

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.